Ashley Brooks
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 10%
- Lipoproteins and Cardiovascular Health
Papers in ⓘ
-
- Diabetes Treatment and Management 3
-
- Pharmacology and Obesity Treatment 2
- Co-authors
- Peter Wijngaard (1 shared paper)Robert S. Kauffman (1 shared paper)Valerie A. Clausen (1 shared paper)Andrew Strahs (1 shared paper)Kevin Fitzgerald (1 shared paper)Akshay Vaishnaw (1 shared paper)Brian R. Bettencourt (1 shared paper)Amy Simon (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (2 papers)Scientific Reports (1 paper)Nature Communications (1 paper)New England Journal of Medicine (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Ashley Brooks
12 papers receiving 909 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 269
- Surgery 377
- Cancer Research 119
- Gastroenterology 30
- Molecular Biology 370
Countries citing papers authored by Ashley Brooks
This map shows the geographic impact of Ashley Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Brooks more than expected).
Fields of papers citing papers by Ashley Brooks
This network shows the impact of papers produced by Ashley Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Brooks. The network helps show where Ashley Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashley Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 Hit paper breakdown → | 2016 | 586 |
| 2 | 2017 | 170 | |
| 3 | 2021 | 61 | |
| 4 | 2023 | 25 | |
| 5 | 2018 | 25 | |
| 6 | 2014 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2016 | 10 | |
| 9 | 2016 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2023 | 3 |
About Ashley Brooks
Ashley Brooks is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Urology, Clinical Biochemistry and Molecular Biology, having authored 12 papers that have together received 927 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (3 papers), Diabetes Treatment and Management (3 papers), Electrolyte and hormonal disorders (2 papers), Pharmacology and Obesity Treatment (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Metabolism and Genetic Disorders (1 paper), Genetic diversity and population structure (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (269 citations), Surgery (377 citations), Cancer Research (119 citations), Gastroenterology (30 citations) and Molecular Biology (370 citations). Ashley Brooks has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Peter Wijngaard, Robert S. Kauffman, Valerie A. Clausen, Andrew Strahs, Kevin Fitzgerald, Akshay Vaishnaw, Brian R. Bettencourt, Amy Simon, Jay D. Horton and Anna Borodovsky. Their work appears in journals such as Diabetes Obesity and Metabolism, Scientific Reports, Nature Communications, New England Journal of Medicine and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.